Clinical Effectiveness of Continuous Infusion Flucloxacillin in the Outpatient Parenteral Antimicrobial Therapy (OPAT) Setting in a UK Hospital: A Service Evaluation

Clinical Effectiveness of Continuous Infusion Flucloxacillin in the Outpatient Parenteral Antimicrobial Therapy (OPAT) Setting in a UK Hospital: A Service Evaluation

The availability of stability data for the use of continuous intravenous flucloxacillin in an elastomeric device has enabled the treatment of serious Methicillin Sensitive <i>Staphylococcus aureus</i> (MSSA) in the outpatient parenteral antimicrobial therapy (OPAT) setting. This service...

Full description

Bibliographic Details
Main Authors:	Annette Margaret Clarkson, Susan Snape
Format:	Article
Language:	English
Published:	MDPI AG 2024-02-01
Series:	Antibiotics
Subjects:	flucloxacillin OPAT continuous infusion <i>Staphylococcus aureus</i> bacteraemia MSSA elastomeric device
Online Access:	https://www.mdpi.com/2079-6382/13/2/153

Similar Items

Clinical Outcomes of an Innovative Cefazolin Delivery Program for MSSA Infections in OPAT
by: Laura Herrera-Hidalgo, et al.
Published: (2022-03-01)

Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program
by: Lore Thijs, et al.
Published: (2022-05-01)

Feasibility, Effectiveness and Safety of Elastomeric Pumps for Delivery of Antibiotics to Adult Hospital Inpatients—A Systematic Review
by: Joseph Spencer-Jones, et al.
Published: (2023-08-01)

Stability of meropenem in portable elastomeric infusion devices: which protocol should be implemented in clinical practice?
by: Beatriz Esteban-Cartelle, et al.
Published: (2024-01-01)

Stability of meropenem in portable elastomeric infusion devices: which protocol should be implemented in clinical practice?
by: Beatriz Esteban-Cartelle, et al.
Published: (2024-02-01)

Efficacy of antibiotic treatment of implant-associated Staphylococcus aureus infections with moxifloxacin, flucloxacillin, rifampin, and combination therapy: an animal study
by: Greimel F, et al.
Published: (2017-06-01)

Effectiveness of outpatient parenteral antimicrobial therapy (OPAT) for patients with cranial infection
by: Fatma Kilinc, et al.
Published: (2023-10-01)

Successful treatment of multiple Nocardia farcinica cerebral abscesses using an outpatient parenteral antimicrobial therapy (OPAT) service
by: Alberto San Francisco, et al.
Published: (2020-04-01)

The Controversial Effect of Antibiotics on Methicillin-Sensitive <i>S. aureus</i>: A Comparative In Vitro Study
by: Valeria C. J. Hackemann, et al.
Published: (2023-11-01)

Synergistic Effects of Pulsed Lavage and Antimicrobial Therapy Against Staphylococcus aureus Biofilms in an in-vitro Model
by: Hervé Poilvache, et al.
Published: (2020-09-01)

Stability of antimicrobial agents in an elastomeric infusion pump used for outpatient parenteral antimicrobial therapy
by: Mutsumi Akahane, et al.
Published: (2021-02-01)

Concomitant Treatment with Voriconazole and Flucloxacillin: A Combination to Avoid
by: Ruth Van Daele, et al.
Published: (2021-09-01)

Palliative outpatient parenteral antimicrobial therapy (OPAT): A single center experience and systematic scoping review
by: Oyewole Chris Durojaiye, et al.
Published: (2022-11-01)

Antibiotic Stewardship in <i>Staphylococcus aureus</i> Bloodstream Infection Treatment—Analysis Based on 29,747 Patients from One Hospital
by: Grzegorz Ziółkowski, et al.
Published: (2020-06-01)

Bilateral acute suppurative parotitis in a 57-day-old girl: an unusual presentation
by: Sofia Poço Miranda, et al.
Published: (2023-10-01)

Acetaminophen Use Concomitant with Long-Lasting Flucloxacillin Therapy: A Dangerous Combination
by: Luuk René van den Bersselaar, et al.
Published: (2020-04-01)

The Role of the Sarak Opat in Resolving Minor Crimes
by: Suhartini Suhartini, et al.
Published: (2022-12-01)

Outcomes of outpatient parenteral antimicrobial therapy (OPAT) for urinary tract infections – A single center retrospective cohort study
by: Sadia Shakoor, et al.
Published: (2023-01-01)

Atypical Presentation of Methicillin-Susceptible <i>Staphylococcus aureus</i> Infection in a Dengue-Positive Patient: A Case Report with Virulence Genes Analysis
by: Soo Tein Ngoi, et al.
Published: (2020-03-01)

Outpatient Parenteral Antimicrobial Therapy for Infective Endocarditis—Model of Care
by: Dylan Rajaratnam, et al.
Published: (2023-02-01)

Antibiotic susceptibility and prevalence of Methicillin-resistant Staphylococcus aureus in different clinical isolates in a tertiary care hospital
by: Nabamita Chaudhury, et al.
Published: (2022-06-01)

Epidemiological studies based on multi-locus sequence typing genotype of methicillin susceptible <i>Staphylococcus aureus</i> isolated from camel’s milk
by: Alsagher O. Ali, et al.
Published: (2017-09-01)

Interaction between posaconazole and flucloxacillin in a lung transplant patient: decrease in plasma exposure of posaconazole and possible undertreatment of invasive aspergillosis: case report
by: Saartje Verfaillie, et al.
Published: (2022-03-01)

Successful Integration of Clinical Pharmacists in an OPAT Program: A Real-Life Multidisciplinary Circuit
by: Sara Ortonobes, et al.
Published: (2022-08-01)

Extensive remodelling of the cell wall during the development of Staphylococcus aureus bacteraemia
by: Edward JA Douglas, et al.
Published: (2023-07-01)

Oral step-down for Staphylococcus aureus bacteraemia: An opportunity for antimicrobial stewardship?
by: Stephen Platts, et al.
Published: (2022-11-01)

Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT
by: Guy E Thwaites, et al.
Published: (2018-10-01)

Adjunctive rifampicin to reduce early mortality from <it>Staphylococcus aureus</it> bacteraemia (ARREST): study protocol for a randomised controlled trial
by: Thwaites Guy, et al.
Published: (2012-12-01)

Infection characteristics and treatment of Staphylococcus aureus bacteraemia at a tertiary children’s hospital
by: Alasdair P. S. Munro, et al.
Published: (2018-08-01)

Current Practices and Opportunities for Outpatient Parenteral Antimicrobial Therapy in Hospitals: A National Cross-Sectional Survey
by: Hester H. Stoorvogel, et al.
Published: (2022-10-01)

Stability Study of Fosfomycin in Elastomeric Pumps at 4 °C and 34 °C: Technical Bases for a Continuous Infusion Use for Outpatient Parenteral Antibiotic Therapy
by: Alessandra Manca, et al.
Published: (2023-09-01)

Target attainment and population pharmacokinetics of flucloxacillin in critically ill patients: a multicenter study
by: Sjoerd D. Meenks, et al.
Published: (2023-03-01)

Alterations in the HLA-B*57:01 Immunopeptidome by Flucloxacillin and Immunogenicity of Drug-Haptenated Peptides
by: Montserrat Puig, et al.
Published: (2021-02-01)

Characterization of <i>Staphylococcus aureus</i> Isolates from Bovine Mastitis and Bulk Tank Milk: First Isolation of Methicillin-Susceptible <i>Staphylococcus aureus</i> in Japan
by: Ryota Miyazawa, et al.
Published: (2022-10-01)

Comparison of genotyping methods and toxin gene profiles of Staphylococcus aureus isolates from clinical specimens
by: Mariana Andrade-Figueiredo, et al.
Published: (2023-12-01)

Characterisation of virulence genes in methicillin susceptible and resistant Staphylococcus aureus isolates from a paediatric population in a university hospital of Medellín, Colombia
by: Judy Natalia Jiménez, et al.
Published: (2011-12-01)

Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus
by: Benjamin H. Gern, et al.
Published: (2018-02-01)

Does biofilm formation have different pathways in Staphylococcus aureus?
by: Ali Shivaee, et al.
Published: (2019-10-01)

Impact of SLCO1B1*5 on Flucloxacillin and Co-Amoxiclav–Related Liver Injury
by: Mohammad Alshabeeb, et al.
Published: (2022-06-01)

Genotypes of <i>Staphylococcus aureus</i> Clinical Isolates Are Associated with Phenol-Soluble Modulin (PSM) Production
by: Harshad Lade, et al.
Published: (2022-08-01)